Author Correction: The SARS-CoV-2 spike protein is vulnerable to moderate electric fields

Author Correction: The SARS-CoV-2 spike protein is vulnerable to moderate electric fields

Bibliographic Details
Main Authors:	Claudia R. Arbeitman, Pablo Rojas, Pedro Ojeda-May, Martin E. Garcia
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-06-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-022-31424-y

Similar Items

Dramatic Differences between the Structural Susceptibility of the S1 Pre- and S2 Postfusion States of the SARS-CoV-2 Spike Protein to External Electric Fields Revealed by Molecular Dynamics Simulations
by: Alexander Lipskij, et al.
Published: (2023-12-01)

Modulating SARS-CoV‑2 Spike Protein Reactivity through Moderate Electric Fields: A Pathway to Innovative Therapies
by: Thi-Huong Nguyen, et al.
Published: (2023-11-01)

Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
by: Tomoyuki Homma, et al.
Published: (2024-01-01)

Molecular dynamics simulations explore effects of electric field orientations on spike proteins of SARS-CoV-2 virions
by: Zhifeng Kuang, et al.
Published: (2022-07-01)

In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants
by: Muhammad Haseeb, et al.
Published: (2023-03-01)

Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV‑2 Infection”
by: Soledad Stagnoli, et al.
Published: (2024-01-01)

Author Correction: Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England
by: Pablo N. Perez-Guzman, et al.
Published: (2023-12-01)

Evolution of the SARS-CoV-2 Omicron spike
by: Ruth J. Parsons, et al.
Published: (2023-12-01)

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
by: Siriruk Changrob, et al.
Published: (2023-04-01)

Author Correction: Interacting topological quantum chemistry in 2D with many-body real space invariants
by: Jonah Herzog-Arbeitman, et al.
Published: (2024-04-01)

Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters
by: Kairat Tabynov, et al.
Published: (2023-08-01)

Correction: The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation.
by: Tiziana Ginex, et al.
Published: (2022-11-01)

Correction: The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation
Published: (2022-11-01)

The Comparison of SARS-CoV-2, SARS-CoV, and MERS-CoV Genome and Spike Protein Variations
by: Choirun Nita Fikriani, et al.
Published: (2021-03-01)

Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion
by: Esteban Dodero-Rojas, et al.
Published: (2021-08-01)

The Elusive Coreceptors for the SARS-CoV-2 Spike Protein
by: Reed L. Berkowitz, et al.
Published: (2022-12-01)

Mutations and Evolution of the SARS-CoV-2 Spike Protein
by: Nicholas Magazine, et al.
Published: (2022-03-01)

Is the Stalk of the SARS-CoV-2 Spike Protein Druggable?
by: Ludovico Pipitò, et al.
Published: (2022-12-01)

The Spike of Concern—The Novel Variants of SARS-CoV-2
by: Anna Winger, et al.
Published: (2021-05-01)

SARS-CoV-2 Spike Protein Interaction Space
by: Claudiu N. Lungu, et al.
Published: (2023-07-01)

Author Correction: Estimation of R0 for the spread of SARS-CoV-2 in Germany from excess mortality
by: Juan Pablo Prada, et al.
Published: (2022-12-01)

Author Correction: Genomic epidemiology of SARS-CoV-2 from Uttar Pradesh, India
by: Gauri Misra, et al.
Published: (2023-10-01)

Author Correction: Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021
by: Anna Yakovleva, et al.
Published: (2023-02-01)

Author Correction: Organ-specific genome diversity of replication-competent SARS-CoV-2
by: Jolien Van Cleemput, et al.
Published: (2022-10-01)

Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope
by: Efi Makdasi, et al.
Published: (2021-03-01)

A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies
by: Fernanda F. Ramos, et al.
Published: (2023-03-01)

SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01)

Temperature impacts SARS-CoV-2 spike fusogenicity and evolution
by: Jérémy Dufloo, et al.
Published: (2024-04-01)

Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
by: Takashi Tanikawa, et al.
Published: (2022-08-01)

Structure-Based Development of SARS-CoV-2 Spike Interactors
by: Flavia Squeglia, et al.
Published: (2022-05-01)

Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein
by: Nozethu Mjokane, et al.
Published: (2022-01-01)

Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
by: Valeria Calvaresi, et al.
Published: (2023-03-01)

In Silico Optimization of SARS-CoV-2 Spike Specific Nanobodies
by: Xiaohong Zhu, et al.
Published: (2023-04-01)

Emergence of SARS‐CoV‐2 spike protein at the vaccination site
by: Annika Beck, et al.
Published: (2023-03-01)

Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike
by: Marco A Díaz-Salinas, et al.
Published: (2022-03-01)

Conformational stability of SARS-CoV-2 glycoprotein spike variants
by: Hiam R.S. Arruda, et al.
Published: (2023-01-01)

Avoiding culture shock with the SARS-CoV-2 spike protein
by: Benjamin G Hale
Published: (2021-05-01)

SARS-CoV-2 Spike protein alters microglial purinergic signaling
by: Vinícius Santos Alves, et al.
Published: (2023-04-01)

Molecular Evolutionary Analyses of the Spike Protein Gene and Spike Protein in the SARS-CoV-2 Omicron Subvariants
by: Norika Nagasawa, et al.
Published: (2023-09-01)

Calreticulin Regulates SARS-CoV-2 Spike Protein Turnover and Modulates SARS-CoV-2 Infectivity
by: Nader Rahimi, et al.
Published: (2023-11-01)